Amphastar Pharmaceuticals (AMPH) Other financing activities (2013 - 2025)

Amphastar Pharmaceuticals' Other financing activities history runs 12 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $8.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.9 million, changed N/A from the prior year.
• Other financing activities improved to $2.0 million in Q4 2025 per AMPH's latest filing, from $379000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $5.7 million in Q4 2021 and bottomed at $379000.0 in Q3 2025.
• The 4-year median for Other financing activities is $2.1 million (2022), against an average of $2.6 million.
• Across the five-year window, Other financing activities soared 205.5% in 2021 and slumped 64.0% in 2022, its largest moves.
• Year by year, Other financing activities stood at $5.7 million in 2021, then slumped by 64.0% to $2.0 million in 2022, then surged by 74.68% to $3.6 million in 2023, then tumbled by 44.33% to $2.0 million in 2025.
• Per Business Quant, the three latest AMPH Other financing activities figures stand at $2.0 million (Q4 2025), $379000.0 (Q3 2025), and $3.6 million (Q4 2023).